BookCrompton, D. W. T.; Daumerie, Denis; Savioli, Lorenzo.
Summary: "The second WHO report builds on the growing sense of optimism generated by the 2012 publication of the WHO roadmap. Commitments on the part of ministries of health in endemic countries, global health initiatives, funding agencies and philanthropists have escalated since 2010, as have donations of medicines from pharmaceutical companies and the engagement of the scientific community. This report marks a new phase and assesses opportunities and obstacles in the control, elimination and eradication of several of these diseases. Unprecedented progress over the past two years has revealed unprecedented needs for refinements in control strategies, and new technical tools and protocols. The substantial increases in donations of medicines made since the previous report call for innovations that simplify and refine delivery strategies. However, some diseases, including especially deadly ones like human African trypanosomiasis and visceral Leishmaniasis, remain extremely difficult and costly to treat. The control of Buruli ulcer, Chagas disease and yaws is hampered by imperfect technical tools, although recent developments for yaws look promising. The report highlights progress against these especially challenging diseases, being made through the development of innovative and intensive management strategies. innovations in vector control deserve more attention as playing a key part in reducing transmission and disease burden, especially for dengue, Chagas disease and the Leishmaniases. Achieving universal health coverage with essential health interventions for neglected tropical diseases will be a powerful equalizer that abolishes distinctions between the rich and the poor, the young and the old, ethnic groups, and women and men."--P. 4 of cover.
Contents:
1 THE GLOBAL PUBLIC-HEALTH AGENDA NOW EMBRACES NEGLECTED TROPICAL DISEASES
1.1 Recent developments in prevention and control
1.2 The roadmap and the London declaration
1.3 Opportunities for public-health programmes
1.4 Costs of expanding activities
1.5 WHO and the roadmap's targets
2 REACHING THE ROADMAP'S TARGETS
2.1 Practical definitions of eradication, elimination, and control
2.2 Obstacles and risks to achieving targets
2.2.1 Conflicts and population displacement
2.2.2 Population growth
2.2.3 Vector control
2.2.4 Resistance to medicines and pesticides
2.2.5 Insufficient capacity for scaling up
2.2.6 Expectations overtaking science
2.2.7 Inadequate support for research
2.2.8 Climate change
3 DISEASES
3.1 Dengue
3.2 Rabies
3.3 Trachoma
3.4 Buruli ulcer
3.5 Endemic treponematoses
3.6 Leprosy
3.7 Chagas disease
3.8 Human African trypanosomiasis (sleeping sickness)
3.9 Leishmaniases
3.10 Taeniasis/cysticercosis
3.11 Dracunculiasis (guinea-worm disease)
3.12 Echinococcosis/hydatidosis
3.13 Foodborne trematodiases
3.14 Lymphatic filariasis
3.15 Onchocerciasis (river blindness)
3.16 Schistosomiasis
3.17 Soil-transmitted helminthiases
4 KEY INTERVENTIONS: SITUATION REPORT
4.1 Preventive chemotherapy
4.2 Innovative and intensified disease management
4.3 Vector control
4.4 Safe water, sanitation and hygiene
4.5 Veterinary public-health services to control neglected zoonotic diseases
4.6 Capacity strengthening.
RequestLocation
Version
Call Number
Items
Books: General Collection (Downstairs)
RC961 .W56 2013
1